© 2024 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
Sophia Z. Humphreys, PharmD, MHA
Sophia Z. Humphreys, PharmD, MHA, BCBBS, is the director of system pharmacy formulary management & clinical programs at Sutter Health in Sacramento, California. She has nearly 20 years of specialized experience in the pharmaceutical industry and is an expert in pharmacy regulatory compliance, US Pharmacopeia General Chapter <797>/<800> pharmacy regulations, clinical education, long-term care pharmacy service, and pharmaceutical waste management. She has a strong background in strategic planning and project management. Prior to her current position, she served as the director of system pharmacy clinical services at Providence St. Joseph Health.
Resources for Patients and Providers on Adalimumab Biosimilars
May 10, 2024
Video
Expert providers in inflammatory diseases provide additional resources on biosimilars and adalimumab biosimilar for patients and providers.
The Role of Nurses and Support Personal in Educating Patient on Adalimumab Biosimilars
May 10, 2024
Video
Providers in inflammatory diseases discuss the instrumental role nurses and support staff play in educating patients on adalimumab biosimilars.
Common Questions From Patients About Adalimumab Biosimilars
May 10, 2024
Video
Drs Lio, Botsoglou, and Alexrad discuss the most asked questions and common concerns patients have on adalimumab biosimilars.
Copay Assistance Programs for Adalimumab Biosimilars
May 03, 2024
Video
Clinicians and a pharmacist discuss how they are managing access and assistance with copay assistance program in their practices.
The Role of Health Care Providers on Encouraging Adalimumab Biosimilar Use
May 03, 2024
Video
Healthcare providers in inflammatory diseases talk about the role they have on encouraging adalimumab biosimilar use in clinical practice.
Clinical Experience With Initiating Adalimumab Biosimilars
April 29, 2024
Video
Specialists in rheumatology, dermatology and gastrointestinal disease share their clinical experience on initiating or switching their patients on adalimumab biosimilars.
Switching From Adalimumab to a Biosimilar
April 29, 2024
Video
Specialists in rheumatology, dermatology and gastrointestinal disease discuss the evidence on efficacy and safety on switching patient to an adalimumab biosimilar.
Selecting Between Adalimumab Biosimilars for Your Patients
April 19, 2024
Video
Providers in rheumatology, dermatology and gastrointestinal disease talk about how they are selecting between the various adalimumab biosimilars available for their patients.
Strategies to Increase Adalimumab Biosimilar Uptake in Clinical Practice
April 19, 2024
Video
A clinical pharmacist and specialists in rheumatology, dermatology, and gastrointestinal disease share strategies in how to increase the uptake of adalimumab biosimilar among providers.
The Role of Pharmacy Benefit Managers and Payers in Accessing Adalimumab Biosimilars
April 12, 2024
Video
A clinical pharmacist discusses the role of pharmacy benefit managers and payers in accessibility of adalimumab biosimilars.